Jersey
# |
Name |
Operating Income Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
-45.72%
|
Dec. 31, 2023 | USD 24.52 | -3.88% |
|
Jersey |
The Clinical Trials company in Jersey with the highest Operating Income Margin is NovoCure Limited (NasdaqGS: NVCR) at -45.72%.
The Clinical Trials company in Jersey with the lowest Operating Income Margin is NovoCure Limited (NasdaqGS: NVCR) at -45.72%.
The top 10 Clinical Trials companies in Jersey by Operating Income Margin are and NovoCure Limited.
The bottom 10 Clinical Trials companies in Jersey by Operating Income Margin are and NovoCure Limited.